Artificial Intelligence
April 23–25, 2018
Boston, MA • United States

Matthew Menard, MD

  • Co-Director, Endovascular Surgery, Brigham and Women's Hospital
  • Assistant Professor, Harvard Medical School

Dr. Matthew Menard is a practicing vascular surgeon at the Brigham and Women’s Hospital in Boston, Massachusetts. Dr. Menard graduated summa cum laude from Middlebury College and earned his medical degree from Harvard Medical School. He received his general surgery training at the Massachusetts General Hospital and vascular surgery fellowship training at the Brigham and Women’s Hospital. He is Co-Director of Endovascular Surgery and the Vascular and Endovascular Surgery Fellowship Program Director at the Brigham and Women’s Hospital.

Dr. Menard is a National Principal Investigator of the BEST-CLI Trial, an NIH-sponsored clinical trial investigating the comparative-effectiveness of open surgery and endovascular therapy for critical limb ischemia (CLI), the only such trial undertaken in North America. The study is a randomized, controlled, superiority trial examining treatment efficacy, functional outcomes and cost following open surgical or endovascular revascularization. The study will enroll 2100 patients with CLI from 150 clinical sites in the United States and Canada who are candidates for both treatment modalities. Dr. Menard has a busy clinical practice equally split between open vascular and endovascular surgery.

This speaker appears at this event: